Add-on Acquisition • Life Science

ULURU Acquires Altrazeal Trading

On May 14, 2015, ULURU acquired life science company Altrazeal Trading for 3M EUR

Acquisition Context

This is ULURU’s 1st transaction in the Life Science sector.
This is ULURU’s 0th largest (disclosed) transaction.
This is ULURU’s 1st transaction in Australia.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	May 14, 2015
Target	Altrazeal Trading
Sector	Life Science
Buyer(s)	ULURU
Deal Type	Add-on Acquisition
Deal Value	3M EUR

Target Company

Altrazeal Trading

Vienna, Australia

Altrazeal Trading GmbH is an innovative wound treatment Altrazeal transforming powder dressing.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Buyer Overview 1

Buyer

ULURU

Addison, Texas, United States

Category	Company
Sector	Life Science
Employees	7
Revenue	864M USD (2014)

DESCRIPTION

ULURU, Inc. is a pharmaceutical company.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Australia	1 of 1
Year: 2015	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Australia M&A - 2015 M&A